Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update

Published:2024-02 Issue:1-2 Volume:24 Page:49-66
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Roccuzzo Gabriele¹,Bongiovanni Eleonora¹,Tonella Luca¹,Pala Valentina¹,Marchisio Sara²,Ricci Alessia²,Senetta Rebecca²,Bertero Luca²^ORCID,Ribero Simone¹,Berrino Enrico³⁴,Marchiò Caterina³⁴,Sapino Anna³⁴,Quaglino Pietro¹,Cassoni Paola²

Affiliation:

1. Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy

2. Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy

3. Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy

4. Department of Medical Sciences, University of Turin, Turin, Italy

Funder

Research Projects of National Relevant Interest

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2024.2314574

Reference133 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Clinical Significance of Distant Metastasis-Free Survival (DMFS) in Melanoma: A Narrative Review from Adjuvant Clinical Trials

3. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care

4. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

5. Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma;Cancers;2024-09-06

2. Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience;Journal of Clinical Medicine;2024-09-04

3. Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives;International Journal of Molecular Sciences;2024-06-30

4. Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced Melanoma;Cancers;2024-05-21

5. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi;Current Oncology;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3